Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02407665 · ClinicalTrials.gov registry record · NA

Tai Chi Intervention and Brain Imaging Study Among Fibromyalgia Patients and Healthy Controls

A NA study, sponsored by Tufts Medical Center.

Completed
Registry status
NA
Development phase
55
Enrollment target

NCT02407665: Completed NA study, sponsored by Tufts Medical Center.

NCT02407665 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02407665, a NA study, has completed, sponsored by Tufts Medical Center.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

This exploratory study proposal is the first pilot brain imaging study to determine if Tai Chi can modulate brain resting state functional connectivity (rsFC) and brain morphometry among fibromyalgia (FM) patients and healthy controls.

Primary Outcome

rostral anterior cingulate cortex (rACC), a key region in descending pain modulatory system (DPMS)

Interventions

  • BEHAVIORAL Tai Chi

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2015-03
Est. Completion 2015-12
Phase NA
Tufts Medical Center

169 total trials

What the finished NCT02407665 record still lists

NCT02407665 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Tai Chi is the first listed.

NCT02407665 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02407665 about?

NCT02407665 is a clinical study titled "Tai Chi Intervention and Brain Imaging Study Among Fibromyalgia Patients and Healthy Controls". This exploratory study proposal is the first pilot brain imaging study to determine if Tai Chi can modulate brain resting state functional connectivity (rsFC) and brain morphometry among fibromyalgia (FM) patients and healthy controls.

What is the current status of trial NCT02407665?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-03. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02407665?

The interventions under investigation include: Tai Chi (BEHAVIORAL).

Who is sponsoring clinical trial NCT02407665?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02407665's enrollment target sits among peer trials

55 1264th of 2000 higher than 733 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02407665, the US trial registry maintained by the National Library of Medicine. NCT02407665 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.